AbbVie Inc (ABBV)

Index:

S&P 100

$ 216.77
   
  • Change Today:
    $0.88
  • 52 Week High: $244.38
  • 52 Week Low: $164.99
  • Currency: US Dollars
  • Shares Issued: 1,765.26m
  • Volume: 118
  • Market Cap: $382,655m
  • RiskGrade: 122
  • Beta: 0.44

Latest ShareCast News

AstraZeneca sells hypertension drug rights; Ends Allergan deal

By Frank Prenesti

Date: Monday 27 Jan 2020

(Sharecast News) - AstraZeneca said it had agreed to sell the global commercial rights to a range of hypertension treatments to Atnahs Pharma for up to $390m.

AbbVie Inc ShareCast News

Botox maker Allergan reports jump in third-quart... 05-Nov-2019 ShareCast
Abbvie snaps up Botox-maker Allergan in $63bn deal 25-Jun-2019 ShareCast
Pharma firms to testify in Congress over drug pr... 26-Feb-2019 ShareCast

AbbVie Inc Newspaper Links

Abbvie boss blasts US tax regime 21-Oct-2014 Telegraph
Drug company AbbVie takeover rival in £31bn bid 18-Jul-2014 Express & Star
AbbVie to announce firm bid for Shire 18-Jul-2014 Telegraph
AbbVie's raised proposal for Shire gets board ba... 15-Jul-2014 Guardian
Shire set to accept £31bn bid from US rival AbbVie 15-Jul-2014 Express & Star

AbbVie Inc Tips & Analysis

No recent information was found.

AbbVie Inc News Wires

No recent information was found.

Note 1: Prices and trades are provided by Digital Look Corporate Solutions and are delayed by at least 15 minutes.

Note 2: RiskGrade figures are provided by RiskMetrics.

 

AbbVie Inc Market Data

Currency US Dollars
Share Price $ 216.77
Change Today $ 0.88
% Change 0.41 %
52 Week High $244.38
52 Week Low $164.99
Volume 118
Shares Issued 1,765.26m
Market Cap $382,655m
Beta 0.44
RiskGrade 122

What The Brokers Say

Strong Buy 8
Buy 12
Neutral 9
Sell 0
Strong Sell 0
Total 29
buy
Broker recommendations should not be taken as investment advice, and are provided by the authorised brokers listed on this page.

Trades for --2025

Time Volume / Share Price
0 @ $0.00

Top of Page